z-logo
open-access-imgOpen Access
Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients
Author(s) -
Kim Min Kyung,
Kim DooMan
Publication year - 2021
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.13552
Subject(s) - medicine , semaglutide , lixisenatide , liraglutide , dulaglutide , type 2 diabetes , exenatide , renal function , diabetes mellitus , kidney disease , glucagon like peptide 1 receptor , albuminuria , endocrinology , agonist , receptor
Glucagon‐like peptide‐1 receptor agonists have been recommended in diabetic kidney disease patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here